| Mr Francisco Zepeda, MS, LMFT | |
|
23 S 8th St Ste 400, Noblesville, IN 46060-2633 | |
| (317) 674-3160 | |
| Not Available |
| Full Name | Mr Francisco Zepeda |
|---|---|
| Gender | Male |
| Speciality | Marriage & Family Therapist |
| Location | 23 S 8th St Ste 400, Noblesville, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215230271 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 106H00000X | Marriage & Family Therapist | MF000676 (Pennsylvania) | Secondary |
| 106H00000X | Marriage & Family Therapist | 35001965A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Francisco Zepeda, MS, LMFT 211 W Rowan Ct, Westfield, IN 46074-9747 Ph: (574) 350-0823 | Mr Francisco Zepeda, MS, LMFT 23 S 8th St Ste 400, Noblesville, IN 46060-2633 Ph: (317) 674-3160 |
News Archive
Scientists from the Walter and Eliza Hall Institute and the University of Melbourne have used innovative new technologies to identify the gene responsible for a rare but fatal hereditary brain disorder. The discovery will make it possible to diagnose the disease through a blood test rather than a brain biopsy.
Chromatrap reports on the advantages of using its Chromatin Immunoprecipitation Sequencing (ChIP-seq) assay kits for histone methylation applications.
Making tumors inside the bladder fluoresce red under blue light allows physicians to more easily find and remove them, substantially reducing the rate at which these cancers come back, says a Mayo Clinic physician who is presenting results of a large, multicenter international clinical trial.
Agenus Inc. announced today that the company has entered into a collaboration and license agreement with Merck, known as MSD outside the United States and Canada, through a subsidiary, for the discovery and development of therapeutic antibodies to immune checkpoints for the treatment of cancer. Under the terms of the agreement, Agenus will discover and optimize fully human antibodies against two undisclosed Merck checkpoint targets using the 4-Antibody Retrocyte Display® platform.
Hospitals facing a growing population of COVID-19 cases need a coordinated approach with a multidisciplinary team to increase efficiency, conserve PPE and protect staff.
› Verified 1 days ago
Mrs. Ann Marie Ravenna, MA, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 54 N 9th St Ste 254, Noblesville, IN 46060 Phone: 317-508-4523 | |
Laura Ann Gibbons, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 23 S 8th St Ste 600, Noblesville, IN 46060 Phone: 800-766-0068 | |
Mrs. Madeline Stealy, LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 23 S 8th St Ste 3500, Noblesville, IN 46060 Phone: 317-934-2177 | |
Morgan Cheyenne Smith, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 23 S 8th St Ste 3700, Noblesville, IN 46060 Phone: 317-645-7691 | |
Jill Brooks, M.S., LMFT Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 23 S 8th St, #3300, Noblesville, IN 46060 Phone: 317-507-9592 | |
Jami Carey, Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 54 N 9th St Ste 260, Noblesville, IN 46060 Phone: 317-645-7691 |